Answers are grounded in this paper and cite their sources.
Cerebrospinal fluid (CSF) secretion by the choroid plexus depends on coordinated ion transport across the blood-CSF barrier (BCSFB). Among basolateral transporters, the Na + -dependent Cl − /HCO 3 − exchanger NCBE (SLC4A10) has emerged as the major transporter responsible for sustaining the intracellular Na + and HCO 3 − required for CSF production. However, its role in choroid plexus transport physiology and its therapeutic potential have not been comprehensively synthesized. A systematic literature review was conducted across MEDLINE, Embase and Web of Science databases. Original peer-reviewed studies evaluating NCBE in the choroid plexus and relevant outcomes in ion transport, CSF dynamics, ventricular volume, or therapeutic modulation were included. Twenty-two studies met inclusion criteria. Across in vitro, in vivo and genetic studies, NCBE consistently localized to the basolateral membrane of choroid plexus epithelial cells and was a major mediator of Na + -dependent HCO 3 − transport. Genetic deletion of SLC4A10 in rodents markedly reduced ventricular volume, impaired intracellular pH recovery, and induced compensatory remodeling of choroid plexus transporter distribution. Human biallelic loss-of-function variants were associated with slit ventricles and neurodevelopmental abnormalities, paralleling in vivo findings. Further studies implicate NCBE regulation in multiple pathologic states including metabolic acidosis and posthemorrhagic hydrocephalus. However, mechanistic investigation has been limited by reliance on non-selective inhibitors which exhibit off-target effects and toxicity. Given its basolateral localization at the BCSFB, predominant enrichment within the CNS, and important role in choroid plexus ion transport, NCBE represents a promising molecular target for pharmacologic modulation of CSF secretion. However, the effect of selective pharmacologic NCBE inhibition on CSF secretion remains to be directly established. Development of selective NCBE inhibitors will enable more precise characterization of NCBE function and may ultimately enable new therapeutic strategies for hydrocephalus and other disorders of CSF dynamics. Graphical Abstract Effect of NCBE (SLC4A10) Knockout on Ventricular Morphology and Cerebrospinal Fluid Transporter Expression. Schematic contrasting wild-type choroid plexus transport (left) against the compensatory remodeling and ventricular morphology changes resulting from NCBE knockout (right). Loss of basolateral NCBE disrupts intracellular pH regulation, blunts apical microvilli, triggers compensatory apical-to-basolateral translocation of NHE1, and downregulates apical secretory machinery expression including Aquaporin 1 (AQP1) and Na + /K + ATPase (NKA).
No takes yet. Share an insight, caveat, or question.
Harper et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: